2026-07-16
Harmony Biosciences issued a press release on July 16, 2026, announcing preliminary net product revenue for the second quarter of 2026 and reaffirming its full-year 2026 net product revenue guidance.
View Full Filing (SEC EDGAR)Harmony Biosciences Holdings
-$287.4M
Net Activity
Institutions Holding
310
Popularity Rank
#1918
Avg Weight
0.08%
Total Value
$1.6B
310 institutions currently hold HRMY, with 167 net buyers and 148 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
148
Net Buying Institutions
167
Top 5 by Value
+$1.0B
Total Buy Value
$713.0M
Total Sell Value
167
Net Buyers
148
Net Sellers
7
Filings (90d)
$5.73M
Total Est. Value
162K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| SANDIP KAPADIA | 2026-07-02 | $924K |
| Kapadia Sandip | 2026-06-30 | $1.80M |
| Kapadia Sandip | 2026-06-26 | $1.61M |
| Kapadia Sandip | 2026-06-24 | $154K |
| Kapadia Sandip | 2026-06-09 | $943K |
| Kapadia Sandip | 2026-06-05 | $70K |
| Kapadia Sandip | 2026-06-04 | $233K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Harmony Biosciences issued a press release on July 16, 2026, announcing preliminary net product revenue for the second quarter of 2026 and reaffirming its full-year 2026 net product revenue guidance.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter